# OnCo record buccal-mucosa-cancer (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/buccal-mucosa-cancer/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "buccal-mucosa-cancer" ;
  schema:name "Buccal mucosa and gingivobuccal cancer (oral cancer in India)"@en ;
  schema:alternateName "Gingivobuccal complex cancer"@en, "Cheek cancer"@en, "Betel quid-associated oral cancer"@en, "Indian oral cancer"@en ;
  schema:description "Cancer of the cheek lining and gums is India's commonest cancer in men, caused by chewing tobacco and areca nut. Surgery with reconstruction is the mainstay, and trials from Tata Memorial in Mumbai have shown that removing the neck nodes up front, cheap oral chemotherapy, tiny doses of immunotherapy and visual screening by health workers all save lives at low cost."@en ;
  schema:url <https://onco.cc/cancers/buccal-mucosa-cancer/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Oral_cancer> ;
  schema:citation <https://en.wikipedia.org/wiki/Oral_cancer> ;
  onco:tag "subtype-page", "head-and-neck" ;
  onco:institutions <https://onco.cc/institutions/tata-memorial/>, <https://onco.cc/institutions/actrec/>, <https://onco.cc/institutions/homi-bhabha-cancer-hospital-varanasi/> ;
  onco:terms <https://onco.cc/terms/extranodal-extension/>, <https://onco.cc/terms/depth-of-invasion/> ;
  onco:pipeline <https://onco.cc/trials/low-dose-nivolumab-tmh/>, <https://onco.cc/trials/metro-plus-varanasi/>, <https://onco.cc/technologies/oral-visual-screening/>, <https://onco.cc/trials/nivopostop/> ;
  onco:standardOfCare <https://onco.cc/trials/kerala-oral-screening/>, <https://onco.cc/technologies/oral-visual-screening/>, <https://onco.cc/trials/elective-neck-dissection-tmh/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/docetaxel/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/fluorouracil/>, <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/trials/metronomic-vs-cisplatin-tmh/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/trials/low-dose-nivolumab-tmh/>, <https://onco.cc/trials/metro-plus-varanasi/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/technologies/smoking-cessation-after-diagnosis/>, <https://onco.cc/technologies/oral-visual-screening/> .